Veterinary Antimicrobial Susceptibility Testing Market Analysis, Trends, Size And Insights 2024 To 2033

The Business Research Company recently released a comprehensive report on the Global Veterinary Antimicrobial Susceptibility Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp

According to The Business Research Company's, The veterinary antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $34.78 billion in 2023 to $37.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to environmental concerns, precision medicine demand, one health approach, consumer awareness, companion animal healthcare growth.

The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $50.45 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to antibiotic resistance mitigation, regulatory requirements, global health events impact, rising pet ownership. Major trends in the forecast period include innovative solutions, regulatory emphasis, zoonotic disease control, livestock industry standards.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report

Market Drivers and Trends:

An increase in pet ownership increases the focus on animal welfare and animal health which is expected to propel the veterinary antimicrobial susceptibility testing market going forward. Pet ownership refers to the act of having and caring for a domesticated animal as a companion or member of the family. Individuals who own pets, often referred to as pet owners, take on the responsibility of providing for the well-being, health, and happiness of their animals. In the context of pet ownership, veterinary antimicrobial susceptibility testing plays a crucial role in ensuring the health and well-being of companion animals. Pet owners, as responsible caregivers, often seek veterinary assistance when their pets exhibit signs of illness or infection. By incorporating veterinary antimicrobial susceptibility testing into pet healthcare practices, pet owners contribute to the overall well-being of their animal companions and actively participate in the responsible stewardship of antimicrobial medications. For instance, according to an article published in April 2022, by Lemonade Inc., a US-based insurance company, approximately 70% of households in the US own a pet in 2022 which is around 90.5 million homes. Therefore, an increase in pet ownership is driving the veterinary antimicrobial susceptibility testing market.

Technological advancements have emerged as a key trend gaining popularity in the veterinary antimicrobial susceptibility testing market. Major companies operating in the veterinary market are focused on innovating new technologies to sustain their position in the market. Recently, the market has witnessed the use of advanced imaging techniques and algorithms for more accurate, reliable, and rapid veterinary AST (antimicrobial susceptibility testing). For instance, in October 2021, Thermo Fisher Scientific, a US-based science and technology company, along with Q-linea launched the ASTar System, a rapid antimicrobial susceptibility testing (rAST) system. The fully automated ASTar System monitors bacterial growth using imaging techniques and algorithms, eliminating the need for subculture, which can take an additional one to two days.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

BioMérieux SA, Becton, Dickinson and Company, Bioguard Corporation, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Cepheid Inc., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, GenMark Diagnostics Inc., IDEXX Laboratories Inc., Luminex Corporation, Merck Co. & KGaA, Microbiologics Inc., Nanosphere Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.

Veterinary Antimicrobial Susceptibility Testing Market 2024 Key Insights:

• The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $50.45 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.
• Veterinary Antimicrobial Susceptibility Testing Market On The Rise Amidst Increasing Zoonotic Disease Prevalence
• Technological Advancements In Antimicrobial Susceptibility Testing Transform The Market
• North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=8177&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.